Cargando…
The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation
Epiberberine (EPI) is a novel and potentially effective therapeutic and preventive agent for diabetes and cardiovascular disease. To evaluate its potential value for drug development, a specific, sensitive and robust high-performance liquid chromatography-tandem mass spectrometry assay for the deter...
Autores principales: | Chen, Ning, Yang, Xiao-yan, Guo, Chang-e, Bi, Xin-ning, Chen, Jian-hua, Chen, Hong-ying, Li, Hong-pin, Lin, Hong-ying, Zhang, Yu-jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749554/ https://www.ncbi.nlm.nih.gov/pubmed/29343943 http://dx.doi.org/10.2147/DDDT.S151660 |
Ejemplares similares
-
In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4
por: Lv, Qiao-Li, et al.
Publicado: (2015) -
Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability
por: K. Pinjari, M. Jakir S., et al.
Publicado: (2017) -
In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
por: Zhang, Ning, et al.
Publicado: (2019) -
In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
por: Li, Yang, et al.
Publicado: (2020) -
Inhibitory Effect of Lygodium Root on the Cytochrome P450 3A Enzyme in vitro and in vivo
por: Zhou, Yunfang, et al.
Publicado: (2020)